Evidence map›Paper›PMID 40025046›Full record

ArticleNature communications2025

Genomically defined hypervirulent Klebsiella pneumoniae contributed to early-onset increased mortality.

Yunfei Tang, Pengcheng Du, Chunjing Du, Ping Yang, Ning Shen, Thomas A Russo, Chao Liu

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Association of Klebsiella pneumoniae sequence type 11 but not other virulence factors with patient mortality: a systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. HypervirulentOpen forum infectious diseases · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yunfei Tang *Department of Infectious Disease, Peking University Third Hospital, Beijing, China.ORCID http://orcid.org/0009-0005-7904-0906
Pengcheng Du *Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. dupengcheng126@126.com.ORCID http://orcid.org/0000-0002-2930-9920
Chunjing DuDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Ping YangDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Ning ShenDepartment of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China. shenningpku@163.com.ORCID http://orcid.org/0000-0001-8783-5403
Thomas A RussoVeterans Administration Western New York Healthcare System, Buffalo, New York, USA. trusso@buffalo.edu.ORCID http://orcid.org/0000-0003-4566-7442
Chao Liu *Department of Infectious Disease, Peking University Third Hospital, Beijing, China. liuchao3619@163.com.ORCID http://orcid.org/0000-0001-5886-4264

Funding

Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae.R21AI141826 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUSSO, THOMAS A · 2020 to 2021
$432k
BLRD VA I01 BX004677Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) NIH 1R21AI141826-01A1National Natural Science Foundation of China (National Science Foundation of China) No. 82200012NIAID NIH HHS R21 AI141826
6 · The paper itself

Abstract

The presence of all five of the virulence-associated genes iucA, iroB, peg-344, rmpA, and rmpA2 is presently the most accurate genomic means for predicting hypervirulent Klebsiella pneumoniae (hvKp-p). With this longitudinal cohort study, we firstly provide novel insights into the clinical and genomic characteristics of hvKp-p in high-risk regions. Through propensity score matching, we show that hvKp-p is less likely to acquire antimicrobial resistance but develops more severe disease and result in increased mortality. HvKp-p are predominantly isolated from hospital settings and caused pneumonia in majority of the cases. ST23 and KL1 are the most common types in the hvKp-p cohort. Community-acquired and healthcare-associated infections are also identified as independent risk factors for hvKp-p. This genomic definition, albeit imperfect, offers a practical and efficient alternative to murine models, allowing for early identification and timely intervention in clinical settings.

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeAdultAgedAnti-Bacterial AgentsBacterial ProteinsCommunity-Acquired InfectionsCross InfectionFemaleGenome, BacterialGenomicsHumansLongitudinal StudiesMaleMiddle AgedRisk FactorsAnti-Bacterial AgentsBacterial ProteinsVirulence Factors

Identifiers

PMID40025046
PMCPMC11873152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.